Pramiconazole

Pramiconazole
Clinical data
Routes of; administration	By mouth
ATC code	none;
Identifiers
	IUPAC name 1-{4-[4-(4-{[(2R,4S)-2-(2,4-difluorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-3-isopropylimidazolidin-2-one;
PubChem CID	3013050; 11411233;
ChemSpider	2281806 ;
UNII	4SYH0R661F;
ChEMBL	ChEMBL175797 ;
Chemical and physical data
Formula	C35H39F2N7O4
Molar mass	659.725 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CC(C)N1CCN(C1=O)c2ccc(cc2)N3CCN(CC3)c4ccc(cc4)OC[C@H]5OC[C@](O5)(Cn6cncn6)c7ccc(cc7F)F;
	InChI InChI=1S/C35H39F2N7O4/c1-25(2)43-17-18-44(34(43)45)29-6-4-27(5-7-29)40-13-15-41(16-14-40)28-8-10-30(11-9-28)46-20-33-47-22-35(48-33,21-42-24-38-23-39-42)31-12-3-26(36)19-32(31)37/h3-12,19,23-25,33H,13-18,20-22H2,1-2H3/t33-,35+/m0/s1 ; Key:AEKNYBWUEYNWMJ-QWOOXDRHSA-N ;
(what is this?) (verify)

Pramiconazole is a triazole antifungal which was under development by Barrier Therapeutics for the treatment of acute skin and mucosal fungal infections but was never marketed.[1]

References

https://adisinsight.springer.com/drugs/800020810

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

[AdisInsight-1] ttps://adisinsight.springer.com/drugs/800020810